Winfield Associates’s Eli Lilly LLY Stock Holding History

Winfield Associates’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-922	Closed	-$79K	–	408
2017 Q4	$79K	Buy	922 +45	+5%	+$3.83K	0.04%	166
2017 Q3	$75K	Buy	877 +2	+0.2%	+$164	0.04%	163
2017 Q2	$72K	Buy	875 +96	+12%	+$7.83K	0.04%	160
2017 Q1	$65K	Sell	779 -25	-3%	-$2K	0.04%	169
2016 Q4	$59K	Buy	804 +324	+68%	+$24.1K	0.04%	170
2016 Q3	$39K	Buy	480 +50	+12%	+$4K	0.02%	192
2016 Q2	$34K	Sell	430 -90	-17%	-$6.78K	0.02%	202
2016 Q1	$38K	Buy	520 +260	+100%	+$19.7K	0.03%	193
2015 Q4	$22K	Hold	260	–	–	0.01%	209
2015 Q3	$22K	Hold	260	–	–	0.02%	202
2015 Q2	$22K	Hold	260	–	–	0.02%	196
2015 Q1	$19K	Hold	260	–	–	0.01%	204
2014 Q4	$18K	Hold	260	–	–	0.01%	207
2014 Q3	$17K	Hold	260	–	–	0.01%	209
2014 Q2	$16K	Hold	260	–	–	0.01%	230
2014 Q1	$15K	Hold	260	–	–	0.01%	220
2013 Q4	$13K	Buy	+260	New	+$13K	0.01%	232

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Winfield Associates's LLY Position: Q1 2018 in Review

Winfield Associates sold out of Eli Lilly (LLY) in Q1 2018, closing a stake of 922 shares — an estimated $79K sold.

Winfield Associates first reported a position in LLY in Q4 2013 and held it in 17 quarters. The position peaked at $79K in Q4 2017. 1,333 funds tracked by Wall St. Rank hold LLY as of Q1 2018.

Winfield Associates reported no remaining Eli Lilly position as of Q1 2018 after selling out during the quarter.
Winfield Associates sold 922 Eli Lilly shares in Q1 2018, an estimated $79K.
Winfield Associates first reported a position in Eli Lilly in Q4 2013 and held it in 17 quarters.
Winfield Associates's Eli Lilly position peaked at $79K in Q4 2017.
1,333 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.